* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings Days Payable Chart
CK Life Sciences International Holdings Annual Data
CKLSF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, CK Life Sciences International Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CK Life Sciences International Holdings Days Payable vs Biotechnology Industry
CK Life Sciences International Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings (CKLSF) has a Days Payable of 55.81 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CK Life Sciences International Holdings and its competitors. This is 64% above median its historical median of 34.06. Over the past decade, CK Life Sciences International Holdings' Days Payable has ranged from 28.69 to 71.01. According to the industry distribution chart, CK Life Sciences International Holdings ranks #479 out of 707 companies in the Biotechnology industry, placing it in the top 67.8%.
Is CK Life Sciences International Holdings' Days Payable too high?
CK Life Sciences International Holdings' current Days Payable of 55.81 is 64% above median its 10-year median of 34.06. Over the past 10 years, this metric has ranged from a low of 28.69 to a high of 71.01. The Biotechnology industry median Days Payable is 113.76. CK Life Sciences International Holdings' value of 55.81 is 50.9% below this industry median. Based on the distribution chart, CK Life Sciences International Holdings ranks #479 out of 707 companies in the Biotechnology industry, which is below the industry midpoint. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #479 out of 707 companies for Days Payable. This places CK Life Sciences International Holdings in the lower half of its industry. The industry median Days Payable is 113.76. CK Life Sciences International Holdings' value of 55.81 is 50.9% below this benchmark. Historically, CK Life Sciences International Holdings' own Days Payable has ranged from 28.69 to 71.01 over the past decade. While the company's 10-year median is 34.06 vs. the industry median of 113.76, CK Life Sciences International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CK Life Sciences International Holdings's current Days Payable of 55.81 is 50.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CK Life Sciences International Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CK Life Sciences International Holdings's current Days Payable is 55.81, which is 64% above median its own 10-year median of 34.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (CKLSF) has a current Days Payable of 55.81. The stock's GF Value™ is $0.10, compared to a current price of $0.09 — trading 10% below its estimated fair value. The current Days Payable is 55.81, which is 64% above median its 10-year median of 34.06 and 50.9% below the Biotechnology industry median of 113.76. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CK Life Sciences International Holdings (CKLSF), the current Days Payable is 55.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CK Life Sciences International Holdings (CKLSF) Overvalued in 2026?
Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued.
The current stock price of $0.09 is trading 10% below its estimated GF Value™ of $0.10.
Key valuation signals for CKLSF:
Days Payable: 55.81 (64% above median its 10-year median of 34.06)
GF Value™: $0.10 vs. price of $0.09 (10% below fair value)
Industry Position: 50.9% below the Biotechnology median (#479 of 707)
No single metric tells the full story. See the CKLSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CK Life Sciences International Holdings Business Description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score
Get the complete analysis for CKLSF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CKLSF has been successfully added to your 
